The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ultravist 240mg/ml Solution for Injection (50ml)

240 milligram(s)/millilitre Solution for injection

Bayer LimitedPA1410/011/001

Main Information

Trade NameUltravist 240mg/ml Solution for Injection (50ml)
Active SubstancesIopromide
Strength240 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderBayer Limited
Licence NumberPA1410/011/001

Group Information

ATC CodeV08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
V08AB05 iopromide

Status

Authorised/WithdrawnAuthorised
Licence Issued24/09/1986
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back